The AHA Scientific Sessions Are Coming to Chicago. Here’s What Cardiologists Are Watching For.
Every November, the cardiology world converges on a single venue to share the science that will shape the next year of clinical practice. This year, that venue is Chicago. The American Heart Association Scientific Sessions 2026 runs November 6–9 at McCormick Place Convention Center, bringing together the full spectrum of cardiovascular science — from foundational research and translational breakthroughs to clinical trial results and real-world application. For a physician like Dr. Christopher Mallavarapu, whose career spans more than three decades of interventional cardiology practice, AHA Scientific Sessions is not just the year’s largest conference. It is where the evidence base for clinical decision-making gets updated in real time.
Why AHA Scientific Sessions Stands Apart
With more than 5,000 presentations across 21 specialties and attendees representing over 100 countries, Scientific Sessions is designed for implementation — giving physicians knowledge they can carry directly into their practice, their research, and their leadership roles. That breadth is part of what makes it the premier event on the cardiovascular calendar. Tracks span drug discovery, electrophysiology, heart failure, vascular disease, arrhythmias, and more — meaning cardiologists across every subspecialty leave with something directly applicable to their patients.
What’s on the Program This Year
AHA Scientific Sessions 2026 will feature late-breaking research, new device data, and practice-changing clinical trial results in cardiology, heart failure, and stroke care, with world-leading cardiologists and principal investigators presenting alongside executives from major cardiovascular device companies. The opening day also includes the AHA’s Innovation Forum, a high-energy, one-day experience designed to help clinicians, scientists, and innovators turn ideas into impact — exploring the real-world path from discovery to startup across cardiovascular and brain health. Notably, Professor Patrick W. Serruys, a world-renowned interventional cardiology expert with four decades of experience pioneering devices and clinical trials, will present a session titled “Coronary Revascularization in 2040” — a forward-looking address that is already drawing significant attention from the interventional community.
Why This Conference Matters for Patients
The research unveiled at AHA Scientific Sessions does not stay in the conference hall. It moves into clinical guidelines, informs treatment protocols, and ultimately changes what physicians recommend to their patients. Dr. Christopher Mallavarapu has built a career grounded in evidence-based cardiac care, and events like AHA Scientific Sessions are a core part of how that commitment stays current. For patients in Olean and Northern Maine, having access to a cardiologist who follows the science this closely means that the standard of care they receive reflects where cardiology actually is — not where it was five years ago. The distance between a Chicago convention center and a regional hospital is shorter than it might seem.